ES8800148A1 - Un procedimiento para la preparacion de un derivado de 2-pirrolidona - Google Patents
Un procedimiento para la preparacion de un derivado de 2-pirrolidonaInfo
- Publication number
- ES8800148A1 ES8800148A1 ES554775A ES554775A ES8800148A1 ES 8800148 A1 ES8800148 A1 ES 8800148A1 ES 554775 A ES554775 A ES 554775A ES 554775 A ES554775 A ES 554775A ES 8800148 A1 ES8800148 A1 ES 8800148A1
- Authority
- ES
- Spain
- Prior art keywords
- preparing
- pharmaceutical composition
- pyrrolidone derivatives
- alkylene
- pyrrolidone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/38—2-Pyrrolones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/50—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cosmetics (AREA)
Abstract
PROCEDIMIENTO PARA PREPARAR UN DERIVADO DE 2-PIRROLIDONA. CONSISTE EN HACER REACCIONAR AL 3,5-DI-T-BUTIL-4-HIDROXIBENZALDEHIDO CON UN COMPUESTO DE FORMULA (II), EN DIMETILFORMAMIDA, ENTRE 0G Y 150GC Y EN PRESENCIA DE TRIETILAMINA, PARA OBTENER UN COMPUESTO DE FORMULA (I) Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. SIENDO: R, H, ALQUILO INFERIOR, ALCOXI INFERIOR O -(CH2)NX; R ELEVADO A 1 Y R ELEVADO A 2, H O ALQUILO INFERIOR; X, FENILO O -NR''R ELEVADO A 2, W, =P(C6H5)3 O -P+(C6H5); Y N, DE 1 A 2. SE UTILIZAN COMO ANTIINFLAMATORIOS Y ANALGESICOS. *FORMULA*
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60096799A JPH066571B2 (ja) | 1985-05-09 | 1985-05-09 | 2−ピロリドン誘導体 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8800148A1 true ES8800148A1 (es) | 1987-11-01 |
ES554775A0 ES554775A0 (es) | 1987-11-01 |
Family
ID=14174668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES554775A Expired ES8800148A1 (es) | 1985-05-09 | 1986-05-08 | Un procedimiento para la preparacion de un derivado de 2-pirrolidona |
Country Status (19)
Country | Link |
---|---|
US (1) | US4833160A (es) |
EP (1) | EP0204964B1 (es) |
JP (1) | JPH066571B2 (es) |
KR (1) | KR910004789B1 (es) |
CN (1) | CN1014058B (es) |
AT (1) | ATE66673T1 (es) |
AU (1) | AU581078B2 (es) |
CA (1) | CA1264762A (es) |
DE (1) | DE3681076D1 (es) |
DK (1) | DK213286A (es) |
ES (1) | ES8800148A1 (es) |
FI (1) | FI84172C (es) |
HU (2) | HU199117B (es) |
MX (1) | MX162717A (es) |
NO (1) | NO861820L (es) |
NZ (1) | NZ216092A (es) |
PH (2) | PH23189A (es) |
PT (1) | PT82540B (es) |
ZA (1) | ZA863352B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5691367A (en) * | 1985-08-09 | 1997-11-25 | Eli Lilly And Company | Aryl-substituted rhodanine derivatives |
US5356917A (en) * | 1985-08-09 | 1994-10-18 | Eli Lilly And Company | Aryl-substituted rhodanine derivatives |
US5089516A (en) * | 1987-03-11 | 1992-02-18 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | 1-phenyl-3,5-pyrazolidinedione hydroxystyrene compounds which have tyrosine kinase inhibiting activity |
EP0304493B1 (en) * | 1987-03-11 | 1992-09-02 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Hydroxystyrene derivatives |
US5202341A (en) * | 1987-03-11 | 1993-04-13 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Hydroxystyrene compounds having tyrosine kinase inhibiting activity |
US5216002A (en) * | 1989-12-21 | 1993-06-01 | Eli Lilly And Company | Method of treating inflammatory bowel disease |
US5143928A (en) * | 1990-03-27 | 1992-09-01 | Warner-Lambert Company | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
ES2106855T3 (es) * | 1991-01-21 | 1997-11-16 | Shionogi & Co | Analogos de 3-benciliden-1-carbamoil-2-pirrolidona. |
JP3150695B2 (ja) * | 1991-04-05 | 2001-03-26 | 鐘淵化学工業株式会社 | フェノキシベンゼン誘導体 |
DE69301894T2 (de) * | 1992-10-28 | 1996-11-07 | Shionogi & Co | Benzylidenderivate |
US5358964A (en) * | 1993-07-26 | 1994-10-25 | Warner-Lambert Company | Benzylidene-lactone and their thiocarbonyl analogs as inhibitors of proteoglycan degradation |
GB9704499D0 (en) | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
CN103342672B (zh) * | 2013-07-02 | 2015-12-23 | 扬州大学 | 取代吡咯烷-2-酮的新合成方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3714153A (en) * | 1970-06-22 | 1973-01-30 | Roussel Uclaf | Novel cyclopropanecarboxylic acids |
DE2329308A1 (de) * | 1972-03-03 | 1975-01-02 | Gruenenthal Chemie | Neue lactame |
AU518986B2 (en) * | 1977-10-11 | 1981-10-29 | Takeda Chemical Industries Ltd. | Lactams |
US4138495A (en) * | 1978-05-19 | 1979-02-06 | Stauffer Chemical Company | N-Substituted pyrrolidones and their use as miticides |
US4440784A (en) * | 1981-02-05 | 1984-04-03 | Kanegafuchi Chemical Industry Company, Ltd. | Anti-inflammatory, analgesic, and antipyretic pharmaceutical composition |
US4431656A (en) * | 1981-02-05 | 1984-02-14 | Kanegafuchi Chemical Industry Company Limited | 3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing the same as an active ingredient |
JPS5879944A (ja) * | 1981-11-09 | 1983-05-13 | Kanegafuchi Chem Ind Co Ltd | 3,5−ジ・タ−シヤリ−・ブチルスチレン誘導体及び抗炎症、鎮痛、解熱剤並びに血小板凝集阻害剤 |
JPS57130950A (en) * | 1981-02-05 | 1982-08-13 | Kanegafuchi Chem Ind Co Ltd | 3,5-di-tert-butyl-4-hydroxystyrene derivative and anti- inflammatory, analgesic, antipyretic agent and inhibitor for blood platelet aggregation |
DE3326724A1 (de) * | 1983-07-25 | 1985-02-07 | Boehringer Ingelheim KG, 6507 Ingelheim | In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte |
JPS6112660A (ja) * | 1984-06-27 | 1986-01-21 | Kanegafuchi Chem Ind Co Ltd | 新規2−ピロリドン誘導体及び抗炎症剤 |
JPH0623194B2 (ja) * | 1985-03-23 | 1994-03-30 | 鐘淵化学工業株式会社 | 新規ラクタム誘導体及び抗炎症剤 |
JPS6412660A (en) * | 1987-07-07 | 1989-01-17 | Canon Kk | Original reader |
JP3611676B2 (ja) * | 1996-06-24 | 2005-01-19 | アサマ化成株式会社 | パン生地の改良剤およびパンの製造方法 |
-
1985
- 1985-05-09 JP JP60096799A patent/JPH066571B2/ja not_active Expired - Lifetime
-
1986
- 1986-04-22 FI FI861698A patent/FI84172C/fi not_active IP Right Cessation
- 1986-04-23 US US06/856,068 patent/US4833160A/en not_active Expired - Fee Related
- 1986-04-28 AU AU56766/86A patent/AU581078B2/en not_active Ceased
- 1986-04-30 PH PH33721A patent/PH23189A/en unknown
- 1986-05-05 ZA ZA863352A patent/ZA863352B/xx unknown
- 1986-05-07 DK DK213286A patent/DK213286A/da not_active Application Discontinuation
- 1986-05-07 DE DE8686106249T patent/DE3681076D1/de not_active Expired - Fee Related
- 1986-05-07 HU HU872041D patent/HU199117B/hu not_active IP Right Cessation
- 1986-05-07 NO NO861820A patent/NO861820L/no unknown
- 1986-05-07 AT AT86106249T patent/ATE66673T1/de active
- 1986-05-07 EP EP86106249A patent/EP0204964B1/en not_active Expired - Lifetime
- 1986-05-08 NZ NZ216092A patent/NZ216092A/xx unknown
- 1986-05-08 HU HU861911A patent/HU196749B/hu not_active IP Right Cessation
- 1986-05-08 ES ES554775A patent/ES8800148A1/es not_active Expired
- 1986-05-08 PT PT82540A patent/PT82540B/pt not_active IP Right Cessation
- 1986-05-08 CA CA000508748A patent/CA1264762A/en not_active Expired - Fee Related
- 1986-05-08 MX MX2417A patent/MX162717A/es unknown
- 1986-05-09 KR KR1019860003628A patent/KR910004789B1/ko not_active Expired
- 1986-05-09 CN CN86103227A patent/CN1014058B/zh not_active Expired
-
1987
- 1987-05-27 PH PH35306A patent/PH23225A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PH23225A (en) | 1989-06-06 |
JPS61257967A (ja) | 1986-11-15 |
DK213286D0 (da) | 1986-05-07 |
HU199117B (en) | 1990-01-29 |
ATE66673T1 (de) | 1991-09-15 |
EP0204964A1 (en) | 1986-12-17 |
HUT43040A (en) | 1987-09-28 |
US4833160A (en) | 1989-05-23 |
JPH066571B2 (ja) | 1994-01-26 |
HU196749B (en) | 1989-01-30 |
HUT45493A (en) | 1988-07-28 |
PT82540A (en) | 1986-06-01 |
FI861698L (fi) | 1986-11-10 |
PH23189A (en) | 1989-05-29 |
AU5676686A (en) | 1986-11-13 |
KR910004789B1 (ko) | 1991-07-13 |
MX162717A (es) | 1991-02-18 |
PT82540B (pt) | 1988-08-17 |
FI84172B (fi) | 1991-07-15 |
ZA863352B (en) | 1986-12-30 |
ES554775A0 (es) | 1987-11-01 |
CA1264762A (en) | 1990-01-23 |
CN86103227A (zh) | 1987-01-21 |
NZ216092A (en) | 1988-08-30 |
FI84172C (fi) | 1991-10-25 |
DK213286A (da) | 1986-11-10 |
CN1014058B (zh) | 1991-09-25 |
KR860008973A (ko) | 1986-12-19 |
AU581078B2 (en) | 1989-02-09 |
NO861820L (no) | 1986-11-10 |
EP0204964B1 (en) | 1991-08-28 |
DE3681076D1 (de) | 1991-10-02 |
FI861698A0 (fi) | 1986-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8800148A1 (es) | Un procedimiento para la preparacion de un derivado de 2-pirrolidona | |
IL93556A0 (en) | Stabilized nitric oxide-primary amine complexes useful as cardiovascular agents | |
DK0412404T3 (da) | Thiazolderivater, fremgangsmåder til fremstilling deraf og farmaceutiske præparater omfattende derivaterne | |
NZ240230A (en) | Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof | |
NZ233735A (en) | Heterocyclic substituted aminophenol derivatives | |
IL87908A (en) | Azaspirane derivatives and immunomodulating pharmaceutical compositions containing same | |
IL111454A0 (en) | Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals | |
MY125749A (en) | Aralkyl and aralkylidene heterocyclic lactams and imides | |
EP0614913A3 (en) | Dynorphin derivatives. | |
YU211087A (en) | Process for obtaining new n-substituted benzimidazolic derivatives | |
AU631025B2 (en) | N-substituted derivatives of 3r, 4r-ethyl-((1-methyl-1h -imidazol-5-yl)methyl)-2-pyrrolidinone | |
MY105538A (en) | Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them. | |
NZ210914A (en) | 4,6,6a,7,8,12b-hexahydroindolo(4,3-ab)phenanthridine,derivatives thereof and pharmaceutical compositions | |
DE2862361D1 (en) | 3,4-methano pyrrolidine derivatives, compositions thereof and use as plant-growth regulating agents | |
ES8301963A1 (es) | Un procedimiento para preparacion de nuevas piperidinoquinazolinas. | |
ES8103082A1 (es) | Procedimiento de preparacion de nuevos derivados pirido (3,4-e)-as-triazinos acilados y de sus sales de acicion aci-da de los mismos | |
HUT50461A (en) | Process for producing imidazole derivatives inhibiting dopamin-beta-hydroxylase and pharmaceutical compositions comprising such compounds | |
LTIP586A (en) | N-substituted heterocyclic derivatives, process fof their preparation, intermediates, process for their preparation and pharmaceutical composition | |
ES2000678A6 (es) | Procedimiento para la obtencion de embonatos de los acidos quinolon-carboxilicos y sus derivados | |
GR3002206T3 (en) | 4-oxo-1,3-benzodioxane derivative | |
UA29449C2 (uk) | N-заміщені похідні 3-азабіцикло[3.2.0]гептану | |
HU9500944D0 (en) | N,n-substituted amino-methylen-imidazolinone derivatives as intermediates of 2-substituted 5-chloro-imidazol-4-carbaldeydes | |
MY103509A (en) | Indole derivatives. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed |
Effective date: 19960506 |